Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6509)
All Articles published online
|
Publishing Process of This Article
|
Feb 14, 2013 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang Y, Luo XM, Yang D, Zhang J, Zhuo HY, Zhang J, Jiang Y. Testing for hepatitis B infection in prospective chemotherapy patients: A retrospective study. World J Gastroenterol 2013; 19(6): 923-930 [PMID: 23429298 DOI: 10.3748/wjg.v19.i6.923] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i6/923.htm |
| Number | Citing Articles |
| 1 |
C.S. Voican, O. Mir, P. Loulergue, M. Dhooge, C. Brezault, J. Dréanic, S. Chaussade, S. Pol, R. Coriat. Hepatitis B virus reactivation in patients with solid tumors receiving systemic anticancer treatment. Annals of Oncology 2016; 27(12): 2172 doi: 10.1093/annonc/mdw414
|
| 2 |
Samuel A. L. Hall, Abdul Shaikh, Kailin Teh, Mahsa Tantiongco, Douglas Coghlan, Chris S. Karapetis, Mohammad A. Chinnaratha, Richard Woodman, Kate R. Muller, Alan J. Wigg. Hepatitis B screening before rituximab therapy: a multicentre South Australian study of adherence. Internal Medicine Journal 2018; 48(8): 936 doi: 10.1111/imj.13740
|
| 3 |
Takeshi Kotake, Hironaga Satake, Yoshihiro Okita, Yukimasa Hatachi, Mamiko Hamada, Masatomo Omiya, Hisateru Yasui, Toru Hashida, Satoshi Kaihara, Tetsuro Inokuma, Akihito Tsuji. Prevalence and risk factors of hepatitis B virus reactivation in patients with solid tumors with resolved HBV infection. Asia-Pacific Journal of Clinical Oncology 2019; 15(1): 63 doi: 10.1111/ajco.13050
|
| 4 |
Ye Eun Kwak, Stacy M. Stein, Joseph K. Lim. Practice Patterns in Hepatitis B Virus Screening Before Cancer Chemotherapy in a Major US Hospital Network. Digestive Diseases and Sciences 2018; 63(1): 61 doi: 10.1007/s10620-017-4850-1
|
| 5 |
Man-Fung Yuen. Need to improve awareness and management of hepatitis B reactivation in patients receiving immunosuppressive therapy. Hepatology International 2016; 10(1): 102 doi: 10.1007/s12072-015-9694-1
|
| 6 |
Chih-An Shih, Wen-Chi Chen. Prevention of hepatitis B reactivation in patients requiring chemotherapy and immunosuppressive therapy. World Journal of Clinical Cases 2021; 9(21): 5769-5781 doi: 10.12998/wjcc.v9.i21.5769
|
| 7 |
Wei-Chih Sun, Ping-I Hsu, Hsien-Chung Yu, Kung-Hung Lin, Feng-Woei Tsay, Huay-Min Wang, Tzung-Jiun Tsai, Wen-Chi Chen, Kwok-Hung Lai, Jin-Shiung Cheng, Ming-Lung Yu. The Compliance of Doctors with Viral Hepatitis B Screening and Antiviral Prophylaxis in Cancer Patients Receiving Cytotoxic Chemotherapy Using a Hospital-Based Screening Reminder System. PLOS ONE 2015; 10(2): e0116978 doi: 10.1371/journal.pone.0116978
|
| 8 |
Tanner Grudda, David L Thomas, Gregory D Kirk, Shruti H Mehta, Jacquie Astemborski, Georg M Lauer, Ashwin Balagopal, Chloe L Thio. Hepatitis B Virus DNA and RNA Persist in Liver After Serologic Recovery in Persons With Hepatitis C Virus. The Journal of Infectious Diseases 2024; doi: 10.1093/infdis/jiae248
|
| 9 |
Chih-An Shih, Wen-Chi Chen, Hsien-Chung Yu, Jin-Shiung Cheng, Kwok-Hung Lai, Jui-Ting Hsu, Hui-Chun Chen, Ping-I Hsu, Yury E Khudyakov. Risk of Severe Acute Exacerbation of Chronic HBV Infection Cancer Patients Who Underwent Chemotherapy and Did Not Receive Anti-Viral Prophylaxis. PLOS ONE 2015; 10(8): e0132426 doi: 10.1371/journal.pone.0132426
|
| 10 |
Wei-Chih Sun, Pei-Ling Tang, Wen-Chi Chen, Feng-Woei Tsay, Huay-Min Wang, Tzung-Jiun Tsai, Sung-Shuo Kao, Jin-Shiung Cheng, Wei-Lun Tsai. Hepatitis B Virus Screening Before Cancer Chemotherapy in Taiwan: A Nationwide Population-Based Study. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.657109
|
| 11 |
Yi-Jun Liao, Yen-Chang Li, Shou-Wu Lee, Chun-Ying Wu, Sheng-Shun Yang, Hong-Zen Yeh, Chi-Sen Chang, Teng-Yu Lee. Lamivudine versus entecavir in the rescue of chemotherapy-induced hepatitis B flare-up. Journal of the Chinese Medical Association 2017; 80(12): 758 doi: 10.1016/j.jcma.2017.07.009
|
| 12 |
Akimasa Sanagawa, Junko Kuroda, Arufumi Shiota, Noriko Kito, Masashi Takemoto, Yoshihiro Kawade, Tetsuo Esaki, Kazunori Kimura. Outcomes of the implementation of the computer-assisted HBView system for the prevention of hepatitis B virus reactivation in chemotherapy patients: a retrospective analysis. Journal of Pharmaceutical Health Care and Sciences 2015; 1(1) doi: 10.1186/s40780-015-0030-7
|
| 13 |
Blanca Sampedro, Cándido Hernández-López, José Ramón Ferrandiz, Aitziber Illaro, Emilio Fábrega, Antonio Cuadrado, Paula Iruzubieta, Susana Menéndez, Joaquín Cabezas, Javier Crespo. Computerized physician order entry-based system to prevent HBV reactivation in patients treated with biologic agents: The PRESCRIB project. Hepatology 2014; 60(1): 106 doi: 10.1002/hep.27103
|
| 14 |
Manzoor A. Wani, Jaswinder S. Sodhi, Showkat A. Zargar, Ghulam N. Yatoo, Altaf Shah, Sheikh A. Aziz, Sajad Geelani, Inaamul Haq, Ghulam M. Gulzar, Mushtaq Khan, Inaamul Haq. Entecavir is Safe and Effective in Long Term for the Treatment of Hepatitis B in Immunocompromised Children. Journal of Clinical and Experimental Hepatology 2020; 10(2): 150 doi: 10.1016/j.jceh.2019.04.002
|
| 15 |
Yu Liu, Zhan-Yi Li, Jia-Ni Wang, Xi Li, Qun-Ai Huang, Yong Huang. Effects of hepatitis C virus infection on the safety of chemotherapy for breast cancer patients. Breast Cancer Research and Treatment 2017; 164(2): 379 doi: 10.1007/s10549-017-4259-8
|
| 16 |
Ping‐I Hsu, Kwok‐Hung Lai, Jin‐Shiung Cheng, Sung‐Shuo Kao, Yuan‐Rung Li, Wei‐Chih Sun, Wen‐Chi Chen, Kung‐Hung Lin, Chih‐An Shin, Po‐Hung Chiang, Yun‐Da Li, Wei‐Ting Ou, Hui‐Chun Chen, Hsien‐Chung Yu. Prevention of acute exacerbation of chronic hepatitis B infection in cancer patients receiving chemotherapy in a hepatitis B virus endemic area. Hepatology 2015; 62(2): 387 doi: 10.1002/hep.27843
|
| 17 |
Ju Dong Yang, Mohit Girotra, Alejandro Restrepo, Sarah Waheed, Bart Barlogie, Andres Duarte-Rojo. Hepatitis B reactivation in patients with multiple myeloma and isolated positive hepatitis B core antibody: a call for greater cognizance. Annals of Hepatology 2014; 13(4): 461 doi: 10.1016/S1665-2681(19)30855-5
|
| 18 |
Yu Liu, Zhan-Yi Li, Xi Li, Jia-Ni Wang, Qun-Ai Huang, Yong Huang. Liver toxicity of chemotherapy and targeted therapy for breast cancer patients with hepatitis virus infection. The Breast 2017; 35: 191 doi: 10.1016/j.breast.2017.08.001
|
| 19 |
Ayşe İnci, Özgür Açıkgöz, Mustafa Uygar Kalaycı, Volkan Ülker. The Positivity Ratios of HBsAg, Anti-HBs and Isolated Anti-HBc in Patients with Breast and Gynecologic Cancers Prior to Chemotherapy. Journal of Clinical and Experimental Investigations 2018; 9(2) doi: 10.5799/jcei.433817
|
| 20 |
Soe Thiha Maung, Natee Deepan, Pakanat Decharatanachart, Roongruedee Chaiteerakij. Screening for viral hepatitis B infection in cancer patients before receiving chemotherapy – A systematic review and meta‐analysis. Asia-Pacific Journal of Clinical Oncology 2024; 20(3): 335 doi: 10.1111/ajco.14055
|
| 21 |
S. Yazaki, T. Yamauchi, T. Higashi. High hepatitis B virus screening rate among patients receiving systemic anticancer treatment in Japan. International Journal of Clinical Oncology 2020; 25(7): 1327 doi: 10.1007/s10147-020-01655-4
|